These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12925960)

  • 1. Smoking, DNA repair capacity and risk of nonsmall cell lung cancer.
    Shen H; Spitz MR; Qiao Y; Guo Z; Wang LE; Bosken CH; Amos CI; Wei Q
    Int J Cancer; 2003 Oct; 107(1):84-8. PubMed ID: 12925960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study.
    Wei Q; Cheng L; Amos CI; Wang LE; Guo Z; Hong WK; Spitz MR
    J Natl Cancer Inst; 2000 Nov; 92(21):1764-72. PubMed ID: 11058619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced DNA repair capacity in lung cancer patients.
    Wei Q; Cheng L; Hong WK; Spitz MR
    Cancer Res; 1996 Sep; 56(18):4103-7. PubMed ID: 8797573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity to DNA damage induced by benzo(a)pyrene diol epoxide and risk of lung cancer: a case-control analysis.
    Li D; Firozi PF; Wang LE; Bosken CH; Spitz MR; Hong WK; Wei Q
    Cancer Res; 2001 Feb; 61(4):1445-50. PubMed ID: 11245449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified host-cell reactivation assay to measure repair of alkylating DNA damage for assessing risk of lung adenocarcinoma.
    Wang L; Wei Q; Shi Q; Guo Z; Qiao Y; Spitz MR
    Carcinogenesis; 2007 Jul; 28(7):1430-6. PubMed ID: 17341660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced DNA repair capacity in head and neck cancer patients.
    Cheng L; Eicher SA; Guo Z; Hong WK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 1998 Jun; 7(6):465-8. PubMed ID: 9641488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients.
    Shi Q; Wang LE; Bondy ML; Brewster A; Singletary SE; Wei Q
    Carcinogenesis; 2004 Sep; 25(9):1695-700. PubMed ID: 15090466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.
    Jarmalaite S; Kannio A; Anttila S; Lazutka JR; Husgafvel-Pursiainen K
    Int J Cancer; 2003 Oct; 106(6):913-8. PubMed ID: 12918069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer.
    Li D; Wang M; Cheng L; Spitz MR; Hittelman WN; Wei Q
    Cancer Res; 1996 Aug; 56(16):3638-41. PubMed ID: 8705998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.
    Hirao T; Nelson HH; Ashok TD; Wain JC; Mark EJ; Christiani DC; Wiencke JK; Kelsey KT
    Cancer Res; 2001 Jan; 61(2):612-5. PubMed ID: 11212258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Joint effects of dietary trace metals and DNA repair capacity in lung cancer risk.
    Mahabir S; Forman MR; Barerra SL; Dong YQ; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2756-62. PubMed ID: 18086784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk factor for squamous cell carcinoma of the head and neck.
    Li D; Firozi PF; Chang P; Wang LE; Xiong P; Sturgis EM; Eicher SA; Spitz MR; Hong WK; Wei Q
    Int J Cancer; 2001 Aug; 93(3):436-40. PubMed ID: 11433411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer.
    Bosken CH; Wei Q; Amos CI; Spitz MR
    J Natl Cancer Inst; 2002 Jul; 94(14):1091-9. PubMed ID: 12122100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the DNA repair gene XRCC1 and risk of primary lung cancer.
    Park JY; Lee SY; Jeon HS; Bae NC; Chae SC; Joo S; Kim CH; Park JH; Kam S; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Jan; 11(1):23-7. PubMed ID: 11815397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene.
    Butkiewicz D; Popanda O; Risch A; Edler L; Dienemann H; Schulz V; Kayser K; Drings P; Bartsch H; Schmezer P
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2242-6. PubMed ID: 15598786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk.
    Qian B; Zhang H; Zhang L; Zhou X; Yu H; Chen K
    Lung Cancer; 2011 Aug; 73(2):138-46. PubMed ID: 21195504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced DNA repair capacity for removing tobacco carcinogen-induced DNA adducts contributes to risk of head and neck cancer but not tumor characteristics.
    Wang LE; Hu Z; Sturgis EM; Spitz MR; Strom SS; Amos CI; Guo Z; Qiao Y; Gillenwater AM; Myers JN; Clayman GL; Weber RS; El-Naggar AK; Mao L; Lippman SM; Hong WK; Wei Q
    Clin Cancer Res; 2010 Jan; 16(2):764-74. PubMed ID: 20068090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck.
    Xiong P; Hu Z; Li C; Wang LE; El-Naggar AK; Sturgis EM; Wei Q
    Int J Cancer; 2007 Dec; 121(12):2735-40. PubMed ID: 17724733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA repair capacity in peripheral lymphocytes predicts survival of patients with non-small-cell lung cancer treated with first-line platinum-based chemotherapy.
    Wang LE; Yin M; Dong Q; Stewart DJ; Merriman KW; Amos CI; Spitz MR; Wei Q
    J Clin Oncol; 2011 Nov; 29(31):4121-8. PubMed ID: 21947825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
    Spitz MR; Wu X; Wang Y; Wang LE; Shete S; Amos CI; Guo Z; Lei L; Mohrenweiser H; Wei Q
    Cancer Res; 2001 Feb; 61(4):1354-7. PubMed ID: 11245433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.